Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_assertion wasGeneratedBy ECO_0000203 NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_assertion wasDerivedFrom befree-20140225 NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_assertion SIO_000772 22329352 NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_assertion evidence source_evidence_literature NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_assertion description "[Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP516877.RAlPkRzdUVN5BJ36CSZWdn8j7VVoJyQRUiQ7Jmd85vYpA130_provenance.